Clinical Trials Browser

INDUSTRY × Neoplasms × lorlatinib × Clear all

NCT05097599 2025-01-08

StrataPATH

Phase 2 Terminated

Neoplasms

NCT03726333 2024-06-21

Hepatic Impairment Study for Lorlatinib in Cancer Patients

Phase 1 Terminated

1 enrolled 3 charts

Lung Neoplasms, Neoplasms